Fennec Pharmaceuticals, Inc. (FRX.TO)
14.76
0.00 (0.00%)
CAD |
TSX |
Oct 23, 16:00
Fennec Pharmaceuticals Profit Margin (Quarterly) : 11.04% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.04% |
| March 31, 2026 | 1.33% |
| December 31, 2025 | -37.34% |
| September 30, 2025 | -5.12% |
| June 30, 2025 | -32.66% |
| March 31, 2025 | -13.31% |
| December 31, 2024 | -20.43% |
| September 30, 2024 | -82.23% |
| June 30, 2024 | -76.47% |
| March 31, 2024 | 50.59% |
| December 31, 2023 | -27.55% |
| September 30, 2023 | -28.66% |
| Date | Value |
|---|---|
| June 30, 2023 | -163.7% |
| March 31, 2023 | -360.9% |
| December 31, 2022 | -446.7% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -1.90K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.40% |
| Return on Assets | -5.81% |
| Return on Invested Capital | -12.94% |
| Gross Profit Margin (Quarterly) | 95.97% |
| Operating Margin (Quarterly) | 9.72% |
| Return on Net Operating Assets | -11.90% |